SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-273355
Filing Date
2020-10-21
Accepted
2020-10-21 08:19:02
Documents
13
Period of Report
2020-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d71632d8k.htm   iXBRL 8-K 27396
2 EX-99.1 d71632dex991.htm EX-99.1 11215
  Complete submission text file 0001193125-20-273355.txt   174376

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20201019.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20201019_lab.xml EX-101.LAB 19657
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20201019_pre.xml EX-101.PRE 12313
6 EXTRACTED XBRL INSTANCE DOCUMENT d71632d8k_htm.xml XML 3642
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 201249673
SIC: 2836 Biological Products, (No Diagnostic Substances)